| Oncolytic reovirus and immune checkpoint inhibition as a novel immunotherapeutic strategy for breast cancer AA Mostafa, DE Meyers, CM Thirukkumaran, PJ Liu, K Gratton, J Spurrell, ... Cancers 10 (6), 205, 2018 | 58 | 2018 |
| Molecular characterization and enzymatic hydrolysis of naringin extracted from kinnow peel waste M Puri, A Kaur, WH Schwarz, S Singh, JF Kennedy International journal of biological macromolecules 48 (1), 58-62, 2011 | 57 | 2011 |
| The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer SS Thakur, H Li, AMY Chan, R Tudor, G Bigras, D Morris, EK Enwere, ... PLoS One 13 (1), e0188983, 2018 | 53 | 2018 |
| Hydrolysis of citrus peel naringin by recombinant α-L-rhamnosidase from Clostridium stercorarium A Kaur, S Singh, RS Singh, WH Schwarz, M Puri Journal of Chemical Technology & Biotechnology 85, 1419-1422, 2010 | 52 | 2010 |
| ING1 induces apoptosis through direct effects at the mitochondria P Bose, S Thakur, K Riabowol Cell Death & Disease 4 (e788), 2013 | 48 | 2013 |
| ING1 and 5-azacytidine act synergistically to block breast cancer cell growth. S Thakur, X Feng, Q Zhong, D Morris, K Riabowol PLoS ONE 7 (8), 2012 | 43 | 2012 |
| Repurposing sunitinib with oncolytic reovirus as a novel immunotherapeutic strategy for renal cell carcinoma KA Lawson, AA Mostafa, ZQ Shi, J Spurrell, W Chen, J Kawakami, ... Clinical Cancer Research 22 (23), 5839-5850, 2016 | 37 | 2016 |
| Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model CM Thirukkumaran, ZQ Shi, GJ Nuovo, J Luider, KA Kopciuk, Y Dong, ... Blood advances 3 (5), 797-812, 2019 | 29 | 2019 |
| Src Regulates the Activity of the ING1 Tumor Suppressor L Yu, S Thakur, R Leong-Quong, D Fujita PLoS ONE 8 (4), 2013 | 24 | 2013 |
| Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma DE Meyers, S Thakur, CM Thirukkumaran, DG Morris Blood Cancer Journal 7 (12), 640, 2017 | 22 | 2017 |
| Reduced ING1 levels in breast cancer promotes metastasis S Thakur, A Singla, K Riabowol Oncotarget 5 (12), 4244-4256, 2014 | 22 | 2014 |
| ING3 protein expression profiling in normal human tissues suggest its role in cellular growth and self-renewal A Nabbi, A Almami, S Thakur, K Suzuki, D Boland, TA Bismar, K Riabowol European Journal of Cell Biology 94 (5), 214-222, 2015 | 20 | 2015 |
| SUMOylation of the ING1b tumour suppressor regulates gene transcription S Satpathy, S Thakur, R Pedeux, K Riabowol Carcinogenesis 35 (10), 2214-2223, 2014 | 18 | 2014 |
| Stromal ING1 expression induces a secretory phenotype and correlates with breast cancer patient survival S Thakur, A Nabbi, A Klimowicz, K Riabowol Molecular cancer 14, 1-13, 2015 | 10 | 2015 |
| Tumor cell apoptosis mediated by cytoplasmic ING1 is associated with improved survival in oral squamous cell carcinoma patients P Bose, S Thakur, J Dort, K Riabowol Oncotarget 5 (10), 3210-3219, 2014 | 10 | 2014 |
| Cytotoxicity and target modulation in pediatric solid tumors by the proteasome inhibitor carfilzomib S Thakur, Y Ruan, A Jayanthan, J Boklan, A Narendran Current Cancer Drug Targets 21 (9), 804-811, 2021 | 5 | 2021 |
| Human SNF5 arming of double-deleted vaccinia virus shows oncolytic and cytostatic activity against central nervous system atypical teratoid/rhabdoid tumor cells S Thakur, Y Ruan, C Zhang, X Lun, A Jayanthan, A Narendran Cancer Gene Therapy 28 (7), 739-744, 2021 | 5 | 2021 |
| The T-type calcium channel Cav3. 1 in Y79 retinoblastoma cells is regulated by the epidermal growth factor receptor via the MAPK signaling pathway U Banderali, M Jain, S Thakur, A Jayanthan, DD Belke, WR Giles, ... Current Eye Research 47 (3), 426-435, 2022 | 4 | 2022 |
| Lin28A/let-7 oncogenic circuit is a potential therapeutic target in neurocutaneous melanosis-associated CNS tumors in children M Jain, S Tran, S Thakur, Y Nagashima, R Anderson, A Narendran Neuro-Oncology Advances 3 (1), vdaa174, 2021 | 3 | 2021 |
| Identification and in vitro validation of neoantigens for immune activation against high-risk pediatric leukemia cells S Thakur, M Jain, C Zhang, C Major, KJ Bielamowicz, NJ Lacayo, ... Human Vaccines & Immunotherapeutics 17 (12), 5558-5562, 2021 | 2 | 2021 |
